Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Kytodent LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, ROBERTS, LEZAH, who is the busiest examiner for the company with 1 pending action. The prosecution is occurring within 1 distinct art unit, which suggests a specialized focus for the current biotechnology claims.
Because there is 1 pending office action, the prosecution risk is concentrated under 1 distinct examiner. ROBERTS, LEZAH is the individual reviewing the 1 pending action, so the legal strategy should be focused on this examiner's specific history and the norms of the 1 art unit involved. This centralized structure in Biotechnology & Pharmaceuticals means that the outcome of the 1 action will define the portfolio's current progress. Practitioners can focus their efforts on a single set of examiner expectations rather than managing multiple prosecution tracks for these medical filings. This approach ensures that the legal strategy is tailored to the individual responsible for the 1 pending action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, LEZAH | 1 | 48.4% | +35.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18198651 | MEDICAL DEVICE SOLUTIONS FOR TREATING DENTAL DISEASE AND METHODS FOR THE TREATMENT OF DENTAL DISEASE | ROBERTS, LEZAH | 30d overdue |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18198651 | MEDICAL DEVICE SOLUTIONS FOR TREATING DENTAL DISEASE AND METHODS FOR THE TREATMENT OF DENTAL DISEASE | ROBERTS, LEZAH | 1612 | §103 | Non-Final OA | 30d overdue | Pending | May 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial